NCT01821547View on ClinicalTrials.gov

New Methods to Measure the Immune Response to Hepatitis B Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2016

Conditions
Hepatitis B
Interventions
DRUG

Hepatitis B vaccine

Immunisation with HepB vaccine (HBvaxPRO, 10μg/ml, Sanofi Pastuer) via intramuscular injection into the non-dominant deltoid (part 1 only).

Trial Locations (1)

OX3 7LE

Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT01821547 - New Methods to Measure the Immune Response to Hepatitis B Vaccine | Biotech Hunter | Biotech Hunter